Cite
HARVARD Citation
Adlam, D. et al. (2022). A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI. International journal of cardiology. pp. 1-7. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Adlam, D. et al. (2022). A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI. International journal of cardiology. pp. 1-7. [Online].